Belgian consensus-based recommendations on the management of hospitalized patients with a penicillin allergy label
Open Access
- 24 July 2026
- journal article
- research article
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 81 (6) , 487-500
Abstract
The prevalence of penicillin allergy labels varies from 10%–20% in United States (US), United Kingdom (UK) and Australian studies to 3%–6% in Belgium or the Netherlands, respectively [1,2], with hi...Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (1805523N)
This publication has 43 references indexed in Scilit:
- Clinical Outcome Associated With Beta‐Lactam Allergy Labels in Hospitalized Patients in BelgiumClinical and Translational Allergy, 2026
- Self-Reported Penicillin Allergy and antibiotic use in critical care: An observational, retrospective studyAnaesthesia Critical Care & Pain Medicine, 2024
- Reaction Risk to Direct Penicillin ChallengesJAMA Internal Medicine, 2024
- Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin AllergyJAMA Internal Medicine, 2023
- The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergyClinical Microbiology and Infection, 2023
- Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision ruleAnnals of Allergy, Asthma & Immunology, 2022
- Development and Validation of a Penicillin Allergy Clinical Decision RuleJAMA Internal Medicine, 2020
- Acute care beta-lactam allergy pathways: approaches and outcomesAnnals of Allergy, Asthma & Immunology, 2019
- Impact of Penicillin Allergy on Time to First Dose of Antimicrobial Therapy and Clinical OutcomesClinical Therapeutics, 2017
- Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort studyJournal of Allergy and Clinical Immunology, 2014